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Head morphogenesis requires complex signal relays to enable precisely coordinated proliferation, migration, and patterning.
Here, we demonstrate that, during mouse head formation, taspase1-mediated (TASP1-mediated) cleavage of the general
transcription factor TFIIA ensures proper coordination of rapid cell proliferation and morphogenesis by maintaining limited
transcription of the negative cell cycle regulators p16Ink4a and p19Arf from the Cdkn2a locus. In mice, loss of TASP1
function led to catastrophic craniofacial malformations that were associated with inadequate cell proliferation. Compound
deficiency of Cdkn2a, especially p16Ink4a deficiency, markedly reduced the craniofacial anomalies of TASP1-deficent mice.
Furthermore, evaluation of mice expressing noncleavable TASP1 targets revealed that TFIIA is the principal TASP1 substrate
that orchestrates craniofacial morphogenesis. ChIP analyses determined that noncleaved TFIIA accumulates at the p16Ink4a
and p19Arf promoters to drive transcription of these negative regulators. In summary, our study elucidates a regulatory circuit
comprising proteolysis, transcription, and proliferation that is pivotal for construction of the mammalian head.

Introduction

Morphogenesis of mammalian heads is a complex process coor
dinating differential cell proliferation, death, migration, and pat
terning in all germ layers. Craniofacial malformations in humans
are major congenital disorders and a primary cause of infant mor
tality (1, 2). More than 700 distinct human craniofacial anomalies
have been described, including cleft lip, cleft palate, Treacher Col
lins syndrome, and holoprosencephaly. However, our knowledge
of the genetic and environmental factors causing these anomalies
is as yet very limited; this has hindered the development of effec
tive treatments and preventative care for most of these anomalies.
Vertebrate animal models have been effective tools for under
standing the conserved molecular processes governing head mor
phogenesis. In mammals, the prospective brain (anterior neuro
ectoderm) is induced by the anterior visceral endoderm and
subsequently transforms into the anterior neural plate. Transcription
factors, such as OTX2, LIM1, SSDP1, and HEX, and signaling path
ways, such as WNT and BMP, define the complex network involved in
this anterior specification (3–8). Upon neurulation, the anterior neural
plate forms a neural tube that subdivides into 3 vesicles: the prosen
cephalon (forebrain), mesencephalon (midbrain), and rhomben
cephalon (hindbrain) (9). When neural progenitor cells increase in
population, the brain vesicles experience robust size expansion, with
a cell cycle time of 7 hours in the prosencephalon and 8.5 hours in
more caudal regions (10, 11). Importantly, cell proliferation is tightly
Conflict of interest: The authors have declared that no conflict of interest exists.
Submitted: May 16, 2014; Accepted: January 5, 2015.
Reference information: J Clin Invest. 2015;125(3):1203–1214. doi:10.1172/JCI77075.

controlled during brain expansion (12, 13). Poor cell cycle regulation
is associated with a variety of head malformations (1, 2). However, the
specific cell cycle factors involved in craniofacial morphogenesis have
remained obscure. Their discovery is challenging, likely due to func
tional redundancy, such that the null alleles of cyclins, cyclin-depen
dent kinases (CDKs), and CDK inhibitors (CDKIs) do not incur overt
craniofacial defects (14, 15).
Site-specific proteolysis regulates a variety of physiological
and cellular processes, including the activation of caspases for
cell death execution and the cleavage of the Notch intracellular
domain for cell fate determination (16). Taspase1 (TASP1; thre
onine aspartase) is a 50-kDa endopeptidase of a family of hydro
lases possessing an asparaginase 2 homology domain (17, 18). Our
initial genetic study of taspase1-null (Tasp1–/–) mice uncovered
a critical role for TASP1 in cell cycle control (19). Tasp1–/– mice
exhibited decreased overall body size; Tasp1–/– mouse embryonic
fibroblasts (MEFs) exhibited impaired cell cycle progression, with
upregulation of CDKIs p16Ink4a, p21Cip1, and p27Kip1 and down
regulation of Ccne1, Ccna2, and Ccnb (19). Bona fide TASP1 sub
strates with conserved IXQL(V)D/G cleavage site motifs include
a ubiquitously expressed general transcription factor TFIIAα-β,
a testis-enriched general transcription factor ALFα-β (TFIIA-like
factor), histone methyltransferases MLL1 (also known as MLL)
and MLL2 (also known as MLL4), and Drosophila HCF (19–22).
We discovered that TASP1-mediated proteolysis activates the full
histone methyltransferase activities of MLL1 and MLL2, which in
turn target cyclin gene promoters via E2F transcription factors (19,
23). On the other hand, it remained unclear how TASP1 mediates
the transcriptional regulation of CDKIs.
jci.org   Volume 125   Number 3   March 2015
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Figure 1. Craniofacial malformations observed in Tasp1–/– mice. (A) Frequencies of live WT, Tasp1+/–, and Tasp1–/– animals observed at the indicated developmental stages. The expected genotype percentages from this intercross are 25%, 50%, and 25% for WT, Tasp1+/–, and Tasp1–/–, respectively. The reduction of the Tasp1–/– frequency between E18.5 and P1 indicates perinatal lethality. (B) Frequencies of the head malformations in WT, Tasp1+/–, and Tasp1–/– P0
pups. Tasp1-deficient animals displayed a range of head and face deformities. (C) Images on the top row are representative Tasp1–/– pups exhibiting smaller
eyes (microphthalmia), absence of eyes (anophthalmia), lack of jaw (agnathia), and rod-like nose (ethmocephaly) as well as complete absence of craniofacial structures anterior to the ears (acephaly). Scale bar: 2.0 mm. Images on the bottom row show malformation of skull derivatives. Skull structures are
identified where indicated. bo, basioccipital bone; bs, basisphenoid; e, exoccipital bone; f, frontal bone; i, interparietal bone; mn, mandible; mx, maxilla; n,
nasal bone; p, parietal bone; pm, premaxilla; s, supraoccipital bone; tp, temporal bone; tr, tympanic ring.

The critical step of mRNA transcription is the recruitment and
assembly of a transcription preinitiation complex, which consists of
RNA polymerase II and general transcription factors (TFIIA, TFIIB,
TFIID, TFIIE, TFIIF, and TFIIH) (24–26). TFIIA enhances transcrip
tion by stabilizing the binding of TATA-binding protein (TBP) at the
promoter DNA and by counteracting the inhibitory effects of nega
tive cofactors, like NC2/Dr1 and TAF1 (27–29). In higher eukaryotes,
TFIIA exists as a heterotrimer composed of 3 subunits: α, β, and γ.
TFIIAα-β is translated as a single polypeptide and site specifically
proteolyzed by TASP1 into α and β subunits (30). Biochemical stud
ies revealed that cleavage of TFIIAα-β increases susceptibility to pro
teasome-mediated degradation but does not affect TFIIA’s ability to
enhance transcription in vitro (31). Importantly, cleaved and non
cleaved TFIIAα-β are equally capable of interacting with the TFIIAγ
subunit and with TBP. Recently, we generated a knockin mouse
expressing a noncleavable mutant form of TFIIAα-β and discovered
that TFIIA proteolysis promotes TFIIA-mediated targeting of TBP-
related factor 2 (TRF2) at the spermiogenic gene loci (Tnp and Prm)
in a testis-specific manner (32). Consequently, TASP1 noncleavable
TFIIAα-β knockin (Tfiianc/nc) mice exhibit male sterility (32).
Here, we report that the TASP1-mediated proteolysis of TFIIAα-β
actively represses the transcription of negative cell cycle regulators
p16Ink4a and p19Arf, transcribed from the Cdkn2a locus, to enable
proper mammalian head development. TASP1 deficiency in mice
leads to fatal craniofacial malformations and impaired telence
1204
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phalic cell proliferation. Noncleaved TFIIAα-β is more stable and
accumulates at p16Ink4a and p19Arf promoters. Excessive p16Ink4a
and p19Arf transcription and aberrant craniofacial formation result
when there is no TASP1 or TASP1 is unable to proteolyze TFIIAα-β.
Together, our genetic and biochemical studies establish what we
believe to be a novel essential pathway for mammalian head mor
phogenesis in which transcription of cell cycle regulators (p16Ink4a
and p19Arf) is modulated via posttranslational site-specific proteoly
sis of a general transcription factor, TFIIAα-β.

Results

TASP1 deficiency leads to craniofacial malformations. Our initial
study of TASP1-deficient mice on a mixed 129SvJ/C57BL/6 (N2)
genetic background revealed that Tasp1–/– pups typically die on P1,
without a visible milk spot (19). Skeletal and histological analysis
revealed that newborn (P0) Tasp1–/– pups had a shortened skull
and a distorted tongue (Supplemental Figure 1, A and B; supple
mental material available online with this article; doi:10.1172/
JCI77075DS1), which suggests that their demise resulted from
suckling defects. Studies in mice deficient for Otx2 or Lim1, two
master transcription factors for mammalian head morphogene
sis, have shown that the murine C57BL/6 genetic background is
associated with greater susceptibility to head malformation (33,
34). Hence, our original line of Tasp1+/– mice was backcrossed to
C57BL/6 mice. Interestingly, backcrossing beyond 6 generations
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Figure 2. Disruption of brain architecture in Tasp1–/– embryos. (A) Lateral views of representative WT and Tasp1–/– embryos at different developmental stages (E8.5–E14.5). Tasp1–/– embryos at E9.5 and older show truncations of head structures (93.8% at E9.5, n = 16; 93.0% at E10.5, n = 41; 100% at
E12.5, n = 12; 94.3% at E14.5, n = 175). Scale bar: 1.0 mm. (B) Hematoxylin and eosin–stained sagittal sections of WT and Tasp1–/– heads at the indicated
developmental stages. Skull structures are identified where indicated. Note the hypoplasia of prosencephalic derivatives in Tasp1–/– embryos. cp, choroid
plexus; cx, cerebral cortex; di, diencephalon; mes, mesencephalon; np, nasal process; oe, olfactory epithelium; os, optic stalk; p, pons; pa, first pharyngeal arch; rh, rhombencephalon; str, striatum; t, tongue; tel, telencephalon. Scale bar: 1.0 mm. (C) Whole-mount anti-CD31 IHC of E10.5 WT and Tasp1–/–
embryos showing spreading of cranial vessels throughout entire heads. At least 3 embryos were tested for each group. Scale bar: 0.5 mm. (D) Hematoxylin and eosin–stained sagittal sections of WT and Tasp1–/– E10.5 embryos. Tasp1–/– hearts are smaller but exhibit normal development. at, atrium; ec,
endocardial cushion; tr, myocardial trabeculae; vn, ventricle. At least 3 embryos were tested for each group. Scale bar: 0.5 mm. (E) Whole-mount in situ
hybridization with Tasp1 antisense and sense (negative control) probes on E10.5 WT embryos. Tasp1 mRNA was detected at brain ventricles, pharyngeal
arches, and limb buds. At least 3 embryos were tested for each probe. Scale bar: 1.0 mm.

resulted in marked infertility of Tasp1+/– males (32). Tasp1–/– mice
were born from Tasp1+/– (N6) intercrosses at near the expected
Mendelian ratio, but all died within the first day after birth (Figure
1A). Strikingly, all these C57BL/6 background–enriched Tasp1–/–
mice displayed arrays of craniofacial malformations, ranging
from smaller eyes (microphthalmia), absence of eyes (anophthal
mia), absence of lower jaw (agnathia), and rod-like nose (ethmo
cephaly) to complete absence of head structures anterior to the
ears (acephaly) (Figure 1, B and C). In acephalic Tasp1–/– pups, the
facial bones rostral to the parietal bones were missing or severely
deformed, whereas caudal bones, such as the interparietal and
suboccipital bones, were present (Figure 1C). On the other hand,
we did not observe overt craniofacial defects in the 129SvJ back
ground–enriched Tasp1–/– pups from intercrosses of Tasp1+/– mice
that had been backcrossed to the 129SvJ strain for 6 generations.

Prenatal examinations of embryos demonstrated that more
than 90% of Tasp1–/– embryos at developmental stages E9.5 to
E14.5 displayed major craniofacial defects, whereas E8.5 Tasp1–/–
embryos were indistinguishable from their WT littermates (Fig
ure 2A and Supplemental Figure 2A). The prosencephalons, nasal
processes, and first pharyngeal arches of Tasp1–/– embryos (E9.5–
E10.5) were hypoplastic or absent (Figure 2, A and B). E14.5–E18.5
Tasp1–/– embryos exhibited severe underdevelopment or complete
absence of the cerebral cortex and striatum as well as absence of
the tongue and lower jaw (Figure 2, A and B). Additionally, most
Tasp1–/– embryos at developmental stages later than E9.5 displayed
smaller trunk sizes compared with those of their WT littermates
(Figure 2A). Interestingly, this marked reduction in body length
distinguishes Tasp1-deficient animals from mice lacking differ
ent head organizer genes, like Otx2-, Lim1-, Ssdp1-, Hex-, Hesx1-,
jci.org   Volume 125   Number 3   March 2015
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Figure 3. Tasp1 loss results in reduced proliferation in the Tasp1–/– developing forebrain. (A) Immunohistochemical staining
for pHH3 reveals reduced mitotic growth in
the prosencephalic region of E10.5 Tasp1–/–
embryos. The percentage of pHH3-positive
cells normalized to Hoechst-positive cells
differed between WT and Tasp1–/– embryos
in the telencephalic neuroectoderm (ne)
but not in the first pharyngeal arch or the
nasal process (n = 3 throughout). Scale
bar: 0.2 mm. Error bars represent SD. *P <
0.05, unpaired 2-tailed Student’s t test. (B)
Apoptotic cells in the E10.5 prosencephalon
were observed by IHC detection of cleaved
caspase-3 (arrowheads). The percentage of
cleaved caspase-3–positive cells normalized to Hoechst-positive cells did not differ
between WT and Tasp1–/– embryos (n = 6
[Tasp1–/–]; n = 5 [WT]). Scale bar: 0.2 mm.
Error bars represent SD.

and Dkk1-deficient animals (5–7, 34–37). Tasp1-deficient animals
have cranial morphogenetic defects, with normal or only slightly
smaller body dimensions. Defects in the cardiovascular system
can impede expansion of embryonic tissues by limiting distribu
tion of nutrient and oxygen. However, this is unlikely the cause for
craniofacial defects in Tasp1–/– embryos, because they exhibited
normal development of cranial blood vessels (Figure 2C) and the
heart (primitive ventricle, atrium, endocardial cushion, and myo
cardial trabeculae) (Figure 2D). Furthermore, whole-mount in situ
hybridization of E10.5 embryos indicated prominent expression of
TASP1 in the brain ventricles, pharyngeal arches, and limb buds
(Figure 2E). This distinct pattern of TASP1 expression is consistent
with the major phenotypes of Tasp1–/– embryos seen in head and
pharyngeal arches.
The telencephalons of Tasp1–/– animals exhibit impaired cell proliferation. Our prior studies using MEFs identified cyclin genes,
genes encoding CDKIs, and Hox genes as the key downstream
transcriptional effectors regulated by TASP1 through site-spe
cific proteolysis of nuclear factors (19). It is unlikely that the Hox
code has any influence on forebrain development, as the cephalic
expression boundary of Hox genes is at the rhombomere (38).
Thus, we focused on investigating whether a disruption of pro
1206
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liferation accounts for the abnormal development of the Tasp1–/–
prosencephalon. In comparison with that in WT embryos, E10.5
Tasp1–/– embryos showed reduced thickness of the telencephalic
neuroectoderm, which was composed of 5 to 8 layers of neural
progenitor cells, rather than the normal 6 to 10 layers (Figure 3A).
Moreover, significantly fewer mitotically active cells were detected
in Tasp1–/– prosencephalons by phospho–histone H3 (pHH3) stain
ing than in WT prosencephalons (Figure 3A). The pHH3-positive
WT cells were ordinarily widely distributed, whereas the few
Tasp1–/– proliferating cells were restricted to the ventricular side
(Figure 3A). On the other hand, comparable proliferation was
detected in Tasp1–/– and WT first pharyngeal arches and nasal com
partments (Figure 3A). Of note, Tasp1–/– and WT E10.5 prosence
phalons showed no difference in apoptosis (Figure 3B).
Cdkn2a deficiency rescues the craniofacial and body size anomalies of Tasp1–/– embryos. To elucidate how TASP1 organizes head
morphogenesis, we performed comparative microarray analyses
on prosencephalons and mesencephalons from E10.5 Tasp1–/–
and WT embryos. Gene Ontology analysis revealed that the
genes that were associated with “cell proliferation” and “met
abolic process” are overrepresented among the genes differen
tially expressed between Tasp1–/– and WT embryo heads (Figure
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Figure 4. Craniofacial and body size anomalies of Tasp1–/– embryos are rescued by Cdkn2a deficiency. (A) RNA harvested from E10.5 WT and Tasp1–/–
heads was subjected to microarray. Gene Ontology analysis shows functional categories of differentially expressed genes in the order of the enrichment
score. (B) GSEA of expression signals from WT and Tasp1–/– samples. Enrichment plot of the “CELL_CYCLE_KEGG” gene set, indicating enrichment of
cell cycle–associated genes among significantly upregulated mRNAs in Tasp1–/– heads (P < 0.01, normalized enrichment scores = 1.57). Genes showing
core enrichment (indicated by inclusion in the purple bar under the enrichment plot) are listed by relative expression (red, high; blue, low). (C) Increased
p16Ink4a and p19Arf mRNA levels were detected in E10.5 Tasp1–/– embryonic heads by quantitative RT-PCR (n = 3 throughout). Error bars represent SD.
*P < 0.05, **P < 0.01, unpaired 2-tailed Student’s t test. (D) Frequencies of the otocephalic phenotypes in E14.5 embryos of the indicated genotypes.
Note that Cdkn2a deficiency significantly rescued Tasp1–/– craniofacial malformations. **P < 0.01, Fisher’s exact test. (E) Body sizes of E18.5 embryos of
the indicated genotypes. The distance from the ears to the base of tail was measured using ImageJ analysis. Note that Cdkn2a deficiency significantly
rescued the reduced body sizes of Tasp1–/– embryos (n = 4 throughout). Error bars represent SD. **P < 0.01, unpaired 2-tailed Student’s t test.

4A). Gene set enrichment analysis (GSEA) of the Molecular Sig
nature Database (C2 canonical pathways) indicates that 4 of the
20 gene sets with the highest normalized enrichment scores are
associated with cell proliferation (Figure 4B and Supplemental
Table 1). These 4 gene sets commonly contain the negative cell
cycle regulators p21Cip1 (also known as Cdkn1a) and Cdkn2a

(Figure 4B). On the other hand, none of the gene sets associ
ated with head development was overrepresented in GSEA. The
Cdkn2a locus encodes 2 distinct proteins from alternative read
ing frames: p16Ink4a, which is a CDKI, and p19Arf, which pro
motes p53-dependent apoptosis and cell cycle arrest (39). Quan
titative RT-PCR analyses demonstrated that the mRNA levels of
jci.org   Volume 125   Number 3   March 2015
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Figure 5. Genetic knockin of cleavage-resistant forms of TASP1 substrates reveals that noncleavage of TFIIAα-β phenocopies the craniofacial malformations observed in Tasp1–/– mice. (A) Mll1nc/nc, Mll2nc/nc, and Mll1nc/nc Mll2nc/nc mice at P0 did not display craniofacial defects. Scale bar: 2.0 mm. (B) WT,
Tfiia+/nc, and Tfiianc/nc mice obtained from Tfiia+/nc intercrosses were observed at the expected Mendelian ratios at the indicated developmental stages.
Nearly 100% of Tfiianc/nc mice died within the first day of birth. (C) Tfiianc/nc P0 animals exhibited head malformations similar to those observed in Tasp1–/–
animals. Scale bar: 2.0 mm. (D) WT and Tfiianc/nc E10.5 and E14.5 embryos with head malformations. Frequencies of the otocephalic phenotypes in E14.5
WT, Tfiia+/nc, and Tfiianc/nc embryos are shown. Scale bar: 1.0 mm.

p16Ink4a, p19Arf, and p21Cip1 were 2- to 3-fold higher in Tasp1–/–
heads than in WT E10.5 heads (Figure 4C). Expression of Ccne1
and Ccna2, which were previously identified as TASP1-regulated
genes in MEFs (19), was only minimally reduced Tasp1–/– heads
(Figure 4C).
We further determined the mRNAs levels of head organizer
genes, including Otx2, Hex, Hesx1, and Dkk1, and did not detect
significantly altered expression in Tasp1–/– E9.5 embryos (Supple
mental Figure 2B). Of note, Hex expression was reduced by 25%
(Supplemental Figure 2B). Since heterozygous loss of Hex does
not induce overt craniofacial aberration (6), the observed Hex
1208
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reduction is unlikely to account for the drastic malformations of
the Tasp1–/– embryo heads. Since MLL1, a substrate of TASP1, was
shown to activate expression of MMP1 and MMP3 via interaction
with ETS2 transcription factor (40) and remodeling of extracellu
lar matrix is important for tissue morphogenesis, we determined
the expression of several MMPs (Supplemental Figure 2C). In
Tasp1–/– E10.5 embryos, Mmp3 was reduced. Of note, mice deficient
in Mmp3 did not exhibit any craniofacial defects (41). Hence, the
Mmp3 reduction is unlikely to account for the overt head defects
of Tasp1–/– animals. There were no significant differences in the
expression of Mt1-Mmp, which is required for cranial skeleton
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Figure 6. Loss of TFIIAα-β proteolysis leads to TFIIA stabilization at the Cdkn2a locus. (A) Quantitative RT-PCR detected increased p16Ink4a, p19Arf, and
p21Cip1 mRNA levels in Tfiianc/nc E10.5 embryo heads relative to levels in WT embryo heads. The mean was calculated from n = 3 (Tfiianc/nc) and n = 5 (WT).
Error bars represent SD. *P < 0.05, **P < 0.01, unpaired 2-tailed Student’s t test. (B) Immunoblots of WT and Tfiianc/nc MEFs validated increased levels of
p16Ink4a and p19Arf proteins in Tfiianc/nc cells. (C) Immunoblots showing levels of TFIIAα, TFIIAα-β, TFIIAγ, TASP1, TBP, and β-actin in WT, Tasp1–/–, and
Tfiianc/nc E10.5 embryo heads. Note the accumulation of TFIIAα-β in the Tasp1–/– and Tfiianc/nc lysates. (D) Illustration depicting the role of TFIIA in p16Ink4a
and p19Arf regulation. During craniofacial development, TASP1-mediated cleavage of TFIIAα-β promotes TFIIA degradation, resulting in limited p16Ink4a
and p19Arf transcription. (E) ChIP assay detected an increase of TFIIA at the Cdkn2a locus of Tfiianc/nc E10.5 embryo heads relative to that in WT embryo
heads. TFIIA binding relative to input was quantified as a percentage by quantitative RT-PCR targeting the p16Ink4a transcription start site (TSS), the
p19Arf transcription start site, and the Cdkn2a 3-kb upstream sequence (control) (n = 4 [Tfiianc/nc]; n = 5 [WT]). Error bars represent SD. *P < 0.05, unpaired
2-tailed Student’s t test.

development, between WT and Tasp1–/– embryos (Supplemental
Figure 2C) (42). Furthermore, Tasp1–/– embryos did not exhibit sig
nificant alteration in the expression of Sox1 and Sox2, two key reg
ulators of neuroectoderm (43). Overall, these results suggest that
TASP1 is necessary for expansion of the prosencephalon, in part
through its restriction of p16Ink4a, p19Arf, and p21Cip1 expression.
To test the hypothesis that cell cycle regulation constitutes the
key mechanism by which TASP1 coordinates mammalian cranial
morphogenesis, we generated mice deficient in both Tasp1 and
Cdkn2a, using Cdkn2a–/– mice, in which both p16Ink4a and p19Arf
are deficient, on a pure C57BL/6 background. Remarkably, the
deletion of Cdkn2a in our Tasp1–/– Cdkn2a–/– mice significantly res
cued the head and body size anomalies of Tasp1–/– mice (Figure 4,
C and D). A greater proportion of E14.5 Tasp1–/– Cdkn2a–/– embryos
developed a normal head (35.9% in Tasp1–/– Cdkn2a–/– embryos

versus 5.7% in Tasp1–/– embryos), and a smaller proportion failed to
develop a prosencephalon (5.1% in Tasp1–/– Cdkn2a–/– embryos ver
sus 18.3% in Tasp1–/– embryos) (Figure 4D). To further understand
how p16Ink4a and p19Arf contribute to craniofacial develop
ment, we generated Tasp1–/– p16Ink4a–/– and Tasp1–/– p19Arf–/– mice,
respectively, using p16Ink4a–/– and p19Arf–/– mice on a C57BL/6
background. Deficiency of p16Ink4a reduced the incidence of
prosencephalon loss (9.7% in Tasp1–/– p16Ink4a–/– embryos versus
18.3% in Tasp1–/– embryos) (Figure 4D). However, neither p16Ink4a
nor p19Arf deficiency alone rescued the gross craniofacial defects
of Tasp1–/– mice. Thus, it is likely that suppression of both p16Ink4a
and p19Arf during cranial morphogenesis is crucial for normal
head development.
Tfiianc/nc mice exhibit the same craniofacial malformations as
Tasp1–/– mice. In mammals, the bona fide substrates proteolyzed
jci.org   Volume 125   Number 3   March 2015
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by TASP1 are TFIIAα-β, ALFα-β, MLL1, and MLL2. ALFα-β is
expressed predominantly in the testes and ovaries (44–46),
whereas TFIIAα-β, MLL1, and MLL2 are expressed ubiquitously,
including in the head. Hence, we investigated whether TASP1mediated cleavage of MLL1, MLL2, or TFIIAα-β contributes
to head morphogenesis. Mll1nc/nc, Mll2nc/nc, and Mll1nc/nc Mll2nc/nc
knockin mice carry homozygous noncleavable mutant Mll1 and/
or Mll2 alleles at their native genomic loci (19, 32). None of these
mice displayed craniofacial defects on a C57BL/6 background
(N10) (Figure 5A). This result is consistent with our previous find
ings in MEFs that TASP1-mediated cleavage of MLLs regulates
cyclin genes but not CDKIs (19). Hence, we generated homozygous
Tfiianc/nc mice (32) that were backcrossed with C57BL/6 mice. Like
Tasp1–/– pups, Tfiianc/nc pups on the C57BL/6 background–enriched
background (N6) were born at the expected Mendelian ratio from
Tfiia+/nc (N6) intercrosses and succumbed to death within the first
day after birth (Figure 5B). Remarkably, Tfiianc/nc and Tasp1–/– mice
displayed closely similar otocephalic phenotypes and diminished
body sizes at birth (Figure 5C) and during embryogenesis (Figure
5D). Of note, Tfiia is expressed ubiquitously in E10.5 embryos
(Supplemental Figure 3A), and thereby, the expression of Tasp1
likely dictates where cleaved TFIIA functions. Notably, none of the
Tfiianc/nc mice exhibited acephaly (P0) or prosencephalon loss
(E14.5). This result suggests that proteolysis of TFIIAα-β may not
be the only way that TASP1 regulates craniofacial development.
Therefore, we generated triple mutant Tfiianc/nc Mll1nc/nc Mll2nc/nc ani
mals. However, introduction of Mll1nc and Mll2nc alleles into Tfiianc/nc
mice did not increase the severity of cranial anomalies (Supple
mental Figure 3B).
Noncleaved TFIIAα-β is stabilized and targets to the Cdkn2a
locus. Thus far, our genetic results demonstrate that (a) Tasp1–/–
mice exhibited severe cranial anomalies with disrupted cell prolif
eration, (b) homozygous loss of Cdkn2a significantly rescued these
defects, and (c) Tasp1–/– mice and Tfiianc/nc mice displayed a highly
similar spectrum of cranial anomalies. Based on these findings, we
hypothesized that TASP1 may promote proper head morphogenesis
through the cleavage of TFIIAα-β to prevent undesirable aber
rant transcription of p16Ink4a and p19Arf. Accordingly, we inves
tigated whether loss of TASP1-mediated cleavage of TFIIAα-β
alters the expression of major cell cycle regulators in Tfiianc/nc
heads. Quantitative RT-PCR and immunoblotting revealed upreg
ulation of p16Ink4a, p19Arf, and p21Cip1 but no changes in the
mRNA levels of of Ccnd1, Ccne1, and Ccna2 (Figure 6, A and B),
supporting TASP1/TFIIA regulation of p16Ink4a/p19Arf/p21Cip1
as an important regulatory axis in cranial morphogenesis.
Next, we examined how TASP1-mediated cleavage of TFIIAα-β
prevents induction of p16Ink4a and p19Arf. Previous studies have
shown that noncleaved TFIIAα-β is less susceptible to proteasomemediated degradation than its cleaved form (31). Consistently,
immunoblotting of TFIIA protein in E10.5 Tasp1–/– and Tfiianc/nc
heads showed an accumulation of noncleaved TFIIAα-β (Figure
6C). Interestingly, the TFIIAγ subunit of TFIIA also exhibited sta
bilization in Tasp1–/– and Tfiianc/nc lysates, albeit to a lesser extent
than TFIIAα-β (Figure 6C). Notably, TFIIAγ exhibited stabilization
in Tasp1–/– and Tfiianc/nc lysates, but not in Tfiia+/nc lysate (Supple
mental Figure 3C), suggesting that TFIIAγ is stabilized only when
all of the TFIIAα-β stays noncleaved. These results suggest that
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TASP1-mediated cleavage of TFIIAα-β contributes to the steadystate transcription by regulating TFIIA turnover. Noncleaved
TFIIAα-β retains its cleaved form’s ability to bind TBP and is tran
scriptionally active (30). Accretion of high levels of noncleaved
TFIIAα-β through either cleavage site mutation (Tfiianc/nc) or loss
of TASP1 function (Tasp1–/–) should therefore increase the associ
ation of TFIIA at the TFIIA target gene loci (Figure 6D). We tested
this hypothesis by performing ChIP assays on the heads of E10.5
Tfiianc/nc and WT embryos. Indeed, we observed a significant
increase in TFIIA occupancy at p16Ink4a and p19Arf promoters in
Tfiianc/nc embryos (Figure 6E).

Discussion

The morphogenesis of the vertebrate head, which is composed of
a group of the most elaborate organs in the body, demands a series
of dynamic events, coordinating the proliferation, migration,
and patterning of different lineages of cells. Brain vesicles, the
prosencephalon, mesencephalon, and rhombencephalon, derive
from the anterior neuroectoderm (9). Defects in induction of the
anterior neuroectoderm in mouse models deficient in Otx2, Lim1,
Ssdp1, and Hex commonly result in the absence of the prosence
phalon by E8.5 and acephaly at P0, if not in prenatal lethality (3–
5). In this study, we identified a variety of craniofacial defects in
Tasp1–/– pups at P0 (Figure 1B). However, Tasp1–/– embryos at E8.5
displayed no overt defects in the prosencephalon (Figure 2A), and
acephaly was an uncommon phenotype of P0 Tasp1–/– pups (Fig
ure 1C). These observations indicate that TASP1 plays a role in the
events subsequent to anterior neuroectoderm induction.
Importantly, the most common phenotype of Tasp1–/– embryos
was hypoplasia of the prosencephalon starting at E9.5 (Figure 2,
A and B). The prosencephalon serves as a signaling center and a
structural support that is critical for the development of craniofa
cial tissues. For example, the optic vesicle, which develops in the
lateral wall of the diencephalon, releases BMP4 and induces the
lens placode (47, 48). Sonic hedgehog (Shh) expressed in the ven
tral prosencephalon is essential for expansion of the frontonasal
process that develops into the nose and upper jaw (49, 50). Further
more, expression of Shh in the anterior foregut endoderm immedi
ately beneath the prosencephalon was shown to be pivotal for the
induction of the first pharyngeal arch, which develops into lower jaw
(51, 52). Consistently, frequency analysis of the craniofacial defects
of Tasp1–/– animals suggested that the shrunken prosencephalon in
E10.5 embryos results in anophthalmia or microphthalmia at E14.5
and P0, while prosencephalon loss at E10.5 results in agnathia in
addition to eye defects (Figure 1C and Supplemental Figure 2A),
suggesting development of eyes is dependent on intact prosence
phalon. Histologically, the hypoplastic prosencephalons of E10.5
Tasp1–/– embryos displayed reduced thickness of the telencephalic
neuroectoderm, overall impaired cell proliferation, and restriction
of a few proliferating cells to the ventricular side (Figure 3A). The
telencephalic neuroectoderm of E10.5 WT embryos consisted pri
marily of the ventricular zone (VZ) on the lumenal side and the sub
ventricular zone (SVZ) on the surface side. In the VZ, apical neural
progenitor cells undergo asymmetric divisions to produce inter
mediate neural progenitor cells and neurons. Intermediate neural
progenitor cells translocate externally to form the SVZ, in which
they undergo symmetric divisions (53). The histological features of

Downloaded from http://www.jci.org on April 14, 2015. http://dx.doi.org/10.1172/JCI77075

Research article

The Journal of Clinical Investigation  
Tasp1–/– embryos suggest that TASP1 may be required primarily for
the division of intermediate neural progenitors in the SVZ and thus
for expansion of the SVZ.
Of all the cranial organs, the brain experiences the most dra
matic expansion during inflation of the brain vesicles. Cell prolif
eration is locally regulated to shape the complex structure of the
brain. For instance, the cells in the alar region of the neural plate
proliferate more than those in the floor region to enable neural
tube closure (13). The cells in the prosencephalic vesicle proliferate
more than the cells at the boundary between the prosencephalon
and the mesencephalon to enable prosencephalon expansion (12).
However, the molecular machinery regulating cell proliferation in
early brain development is poorly understood. Several cell cycle
regulators, including cyclin D2, p21Cip1, p27Kip1, and p57Kip2,
have been implicated in corticogenesis but not in early craniofacial
development (54–56). None of the mouse models with cyclin,
CDK, or CDKI deficiency exhibit critical craniofacial defects
other than changes in the thickness of limited cerebral cortical lay
ers (14, 15), most likely because of functional redundancy among
cell cycle regulators. The relevance of negative cell cycle regula
tors p16Ink4a and p19Arf to embryonic development has long
been dismissed, as their expression is barely detectable in mouse
embryos (E7.5–E17.5) by Northern blot (57). However, p16Ink4a
and p19Arf levels increase over passages of MEFs, suggesting that
p16Ink4a and p19Arf transcription is actively repressed during
embryogenesis (57). Here, we discovered that TASP1 depletion
leads to robust upregulation of p16Ink4a and p19Arf in developing
mouse heads (Figure 4C). We showed that compound deficiency
of Cdkn2a, the locus from which p16Ink4a and p19Arf are tran
scribed, significantly rescues the craniofacial anomalies of Tasp1–/–
animals, thereby demonstrating that p16Ink4a and p19Arf play an
important role in craniofacial development (Figure 4C). Cdkn2a
deficiency rescued all of the observed craniofacial phenotypes of
Tasp1–/– embryos, including anophthalmia and agnathia, indicat
ing that cell cycle deregulation is the principal defect that TASP1
depletion causes. However, Cdkn2a deficiency did not affect a
complete rescue: more than 60% of Tasp1–/– Cdkn2a–/– animals
still showed craniofacial defects (Figure 4C). One hypothesis that
accounts for this incomplete rescue is that p21Cip1, another CDKI
that showed upregulation in Tasp1–/– embryos, also contributes to
craniofacial defects and that p21Cip1 and p16Ink4a have redun
dant roles in cell cycle regulation. This hypothesis could be tested
by examining the rescue of Tasp1–/– phenotypes by deficiencies of
both Cdkn2a and p21Cip1. An alternative hypothesis is that cell
cycle regulation is not the only mechanism by which TASP1 coor
dinates craniofacial morphogenesis. This latter hypothesis is sup
ported by our characterization of Tfiianc/nc embryos, none of which
exhibited prosencephalon loss at E14.5 or acephaly at P0 (Figure
5, B–D), despite displaying clear upregulation of p16Ink4a, p19Arf,
and p21Cip1 (Figure 6A).
In a previous study on MEFs, we demonstrated that TASP1
loss leads to concurrent downregulation of Ccne1, Ccna2, and
Ccnb and upregulation of CDKIs p16, p21, and p27 (19). We also
provided evidence that TASP1 helps MLL1 and MLL2 regulate the
expression of cyclin genes by activating their histone methyltrans
ferase activities (ref. 19 and Supplemental Figure 4). Interestingly,
we did not observe significant downregulation of cyclin genes in

the Tasp1–/– embryo heads, possibly reflecting the tissue specificity.
In addition to cyclin genes, MLL1 and MLL2 also drive transcrip
tion of Hox genes, which regulate specification of the anterior-
posterior axis during embryogenesis (38). However, Hox genes
seem irrelevant to the craniofacial anomalies caused by TASP1
deficiency, because no Hox genes are expressed anterior to the
rhombencephalon, and none of the Hox-deficient mouse models
reportedly display craniofacial phenotypes observed in Tasp1–/–
embryos (Mouse Genome Informatics, http://www.informatics.
jax.org). Consistently, Mll1nc/nc, Mll2nc/nc, and Mll1nc/nc Mll2nc/nc mice
displayed no obvious craniofacial defects, thus we concluded that
TASP1-mediated proteolysis of MLL1 and MLL2 is dispensable for
normal head development.
In contrast to cyclin genes, how TASP1 controls the tran
scription of CDKIs has been an open question. Here, we discov
ered that failure in TASP1-mediated proteolysis of TFIIAα-β in
Tfiianc/nc animals resulted in a robust increase of p16Ink4a and
p19Arf (Figure 6, A and B), thus demonstrated a signaling cas
cade that we believe to be novel comprising TASP1 (protease),
TFIIA (general transcription factor), and CDKN2A (cell cycle
regulators). We displayed in mouse embryos that noncleavage
of TFIIAα-β leads to increased protein stability of TFIIAα-β and
TFIIAγ, consistent with the previous finding in vitro that TASP1mediated proteolysis of TFIIAα-β accelerates proteasomemediated degradation (31). Noncleaved TFIIAα-β was shown to
interact with TBP and TFIIAγ and enhance transcription as effi
ciently as its cleaved form (31, 58). Consequently, our findings in
vivo suggest that the primary function of TASP1-mediated TFIIA
proteolysis is the regulation of cellular levels of TFIIA. Our
ChIP assays showed that stabilization of TFIIAα-β in Tfiianc/nc
embryos leads to significantly increased TFIIA occupancy on
p16Ink4a and p19Arf promoters. Accordingly, we concluded that
TASP1 cleaves TFIIAα-β to prevent excess recruitment of TFI
IAα-β to p16Ink4a and p19Arf promoters during mammalian cra
nial morphogenesis. Recently, we elucidated a specific role for
TASP1-mediated proteolysis of TFIIAα-β in mammalian sper
matogenesis (32). Proteolysis activated TFIIA’s ability to recruit
TRF2 for the upregulation of spermiogenic genes (Tnp and Prm)
through targeting respective promoters (Supplemental Figure
4), and Tfiianc/nc animals display immature spermiogenesis in
spite of the improved protein stability that noncleavage confers
on TFIIAα-β (32). Notably, it is unlikely that recruitment of TRF2
by proteolyzed TFIIAα-β occurs during craniofacial morphogen
esis, because the phenotype of TRF2-deficient mice is limited
to defects in spermiogenesis. Animals deficient in TRF2 incur
neither other embryogenesis defects nor lethality (59). Hence,
TASP1 uses various strategies to achieve sophisticated control
over diverse biological processes.

Methods

Mice and skeletal studies. Tasp1–/–, Mll1nc/nc, Mll2nc/nc, and Tfiianc/nc mice
were generated as previously described (19, 32). p16Ink4a–/– (FVB.129-
Cdkn2atm2.1Rdp), p19Arf–/– (B6.129-Cdkn2atm1Cjs), and Cdkn2a–/– (B6.129-
Cdkn2atm1Rdp) mice were purchased from the NCI Mouse Repository.
Tasp1+/–, Tfiia+/nc, and p16Ink4a–/– mice were backcrossed with C57BL/6
animals for 6 generations (N6) and maintained by intercrosses. Mll1nc/nc
and Mll2nc/nc mice were backcrossed with C57BL/6 mice for 10 gener
jci.org   Volume 125   Number 3   March 2015
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ations (N10). Skeletal studies were performed as previously described
(19). Briefly, skulls were stained with alizarin red and alcian blue for
visualization of bone and cartilage, respectively. Mouse embryos and
P0 pups were photographed with an Infinity camera (Lumenera) under
a stereoscopic microscope (Zeiss Stemi 2000-C, Zeiss). For measure
ment of embryo body sizes, a digital image of each embryo was con
verted into a binary file. The distance between the ears and the tail
base was then calculated using the Measure Roi Curve plug-in for the
ImageJ software program.
MEFs. MEFs were harvested from WT and Tfiianc/nc E13.5 mouse
embryos according to the standard protocol (60). MEFs were cultured
in Iscove’s Modified Dulbecco’s Medium supplemented with 20%
fetal bovine serum.
Histology, immunohistochemistry, and cell quantification. Tissues
or whole embryos were collected and fixed in 4% paraformaldehyde
(PFA) or Bouin’s solution. Paraffin-embedded samples were sectioned
(5–7 μm), rehydrated, and subjected to hematoxylin and eosin stain
ing, immunohistochemistry (IHC), or Hoechst (Invitrogen) staining.
For IHC of sections, samples were blotted with the antibody specific
to pHH3 Ser10 (06-570, Upstate) or cleaved Caspase-3 (9661, Cell
Signaling) and visualized with DAB and nickel chloride (Vector Labs).
For whole-mount IHC, E10.5 embryos were bleached in 6% H2O2/
methanol and dehydrated in 100% methanol. Samples were blocked
in 5% skim milk and 1% Triton X-100 in PBS and incubated with antiCD31 antibody (557355, BD Pharmingen). Following incubation with
peroxidase-conjugated anti-rat IgG, staining was visualized with the
DAB Peroxidase Substrate Kit (Vector Labs). Images were acquired
with a SPOT camera (Diagnostics Instruments) mounted on an Olym
pus IX51 microscope (Olympus). Where indicated, cell numbers were
determined using the ITCN plug-in for the ImageJ software program
and normalized to the number of Hoechst-positive cells.
In situ hybridization. Whole-mount in situ hybridization was per
formed on E10.5 mouse embryos. The cDNAs of mouse Tasp1 and
Tfiia1 were used as the templates to generate RNA probes. Embryos
were fixed with 4% PFA in PBS, permeabilized with proteinase K, and
then post-fixed with 4% PFA and 0.2% glutaraldehyde in PBS. Hybrid
ization was performed overnight at 65°C with DIG-labeled RNA probes
in hybridization buffer (50% formamide, 5x SSC, 0.3 mg/ml yeast
RNA, 0.1 mg/ml heparin, 1x Denhardt’s, 0.1% Tween 20, and 5 mM
EDTA). Embryos were washed with 50% formamide in 2x SSC, blocked
in 1.5% Blocking Reagent (Roche) in KTBT (50 mM Tris-HCl, 140 M
NaCl, 10 mM KCl, 0.1% Tween 20), and incubated overnight at 4°C
with AP-conjugated anti-DIG Fab fragments (Roche). After extensive
washes, the color reaction was carried out using BM purple (Roche).
RNA isolation, quantitative RT-PCR, and microarray analysis. For
RNA isolation, surgically dissected E10.5 mouse heads (prosencephalons
and mesencephalons) were homogenized in TRIzol reagent (Invitrogen)
using FastPrep-24 and Lysing Matrix D (MP Biomedicals). cDNA was
produced from total RNA extracted using SuperScript II (Invitrogen),
oligo-dT (Invitrogen), and random decamer primers (Ambion) accord
ing to the manufacturer’s instructions. Quantitative RT-PCR was per
formed using SYBR Green Master Mix (Applied Biosystems), gene-spe
cific oligonucleotide primers (listed in Supplemental Table 2), and the
1. Copp AJ, Greene ND. Genetics and development of
neural tube defects. J Pathol. 2010;220(2):217–230.
2. Trainor PA. Craniofacial birth defects: The role
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ViiA7 Real-Time PCR System (Applied Biosystems). Gene expression
data were normalized against Gapdh detected using a Gapdh TaqMan
probe (Applied Biosystems). For microarray analysis, samples prepared
from RNA isolated from E10.5 prosencephalons and mesencephalons
were hybridized to GeneChip Mouse ST 1.0 (Affymetrix). The expression
signals were subjected to Gene Ontology analysis (Partek) and GSEA
(http://www.broadinstitute.org/gsea/index.jsp) to identify overrepre
sented groups of genes, with common biological processes or pathways.
Microarray data were deposited in GEO (accession no. GSE64533).
Immunoblot analysis. Dissected E10.5 mouse heads (prosence
phalons and mesencephalons) or E13.5 primary MEFs at passage P2
were lysed in RIPA buffer supplemented with complete protease inhib
itors (Roche). The mouse head lysates were homogenized for complete
dissociation using FastPrep-24 and Lysing Matrix D (MP Biomedicals).
Samples were loaded onto NuPAGE gels (Invitrogen) and transferred
onto PVDF (Immobilon-P, Millipore). Proteins of interest were blotted
with specific antibodies and detected with enhanced chemilumines
cence reagents (Western Lightening, Perkin Elmer) and the LAS-300
Imaging System (FUJIFILM Life Science). Antibodies against TASP1
and TFIIAα (SM346) are as previously described (32, 61); antibodies
against p16Ink4a (sc74401, Santa Cruz), p19Arf (ab26696, Abcam),
TFIIAγ (sc5316, Santa Cruz), TBP (sc204, Santa Cruz), and anti–βactin (AC-15, Sigma-Aldrich) were purchased commercially. See com
plete unedited blots in the supplemental material.
ChIP assay. Tissue was collected from the prosencephalons, mesen
cephalons, upper jaws, and eyes (but not from the rhombencephalons and
lower jaws) of E12.5 mouse embryos; minced with a razor blade; and fixed
with 1% PFA. The approximately 10 mg chromatin obtained from 4 × 106
to 5 × 106 cells was sonicated using a Bioruptor (Diagenode) for 28 min
utes to sheer the DNA into fragments of 100 to 400 base pairs. Immuno
precipitation was performed using antibodies against TFIIAα (MO431) or
rabbit IgG (Sigma-Aldrich) and anti-rabbit IgG Dynabeads (Invitrogen).
The anti-TFIIAα antibody was generated by immunizing rabbits against
the peptide encompassing aa 1–276 of human TFIIAα-β. Precipitated
DNA was assessed by quantitative RT-PCR using gene-specific oligonu
cleotide primers (listed in Supplemental Table 2). The immunoprecipita
tion efficiency was determined as the percentage relative to input.
Statistics. Results are presented as mean ± SD. Except where otherwise
specified, statistical significance was determined by unpaired 2-tailed
Student’s t test. A P value of less than 0.05 was considered significant.
Study approval. All animal work was performed in accordance to a
protocol approved by the Institutional Animal Care and Use Commit
tee of Memorial Sloan-Kettering Cancer Center.
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